Business Description
Croma NV
ISIN : NL0015000K10
Share Class Description:
STU:QX0: Class ADescription
Croma NV Formerly European Healthcare Acquisition Growth Co BV is a special purpose acquisition company aimed at acquiring companies with principal operations in Europe in the healthcare sector, with a special focus on the subsectors Biotechnology and Specialty Pharma, Pharma Services, Medical Technology and Medical Devices, Diagnostic and Lab Services, Bioinformatics as well as Life Science Tools.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.1 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.57 | |||||
| 9-Day RSI | 55.93 | |||||
| 14-Day RSI | 51.84 | |||||
| 6-1 Month Momentum % | -15.25 | |||||
| 12-1 Month Momentum % | -23.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.11 | |||||
| Quick Ratio | 1.11 | |||||
| Cash Ratio | 0.07 | |||||
| Days Payable | 1546.66 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | 852.32 | |||||
| ROA % | 4.73 | |||||
| ROIC % | -1.59 | |||||
| ROCE % | 1818.94 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 19.4 | |||||
| PB Ratio | 45.23 | |||||
| Price-to-Tangible-Book | 44.12 | |||||
| EV-to-EBIT | 8.8 | |||||
| EV-to-EBITDA | 8.8 | |||||
| EV-to-FCF | -116.5 | |||||
| Price-to-Net-Current-Asset-Value | 44.12 | |||||
| Earnings Yield (Greenblatt) % | 11.36 | |||||
| FCF Yield % | -0.85 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Croma NV Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | 0.464 | ||
| Beta | 0 | ||
| Volatility % | 66.62 | ||
| 14-Day RSI | 51.84 | ||
| 14-Day ATR (€) | 0.05562 | ||
| 20-Day SMA (€) | 7.5 | ||
| 12-1 Month Momentum % | -23.08 | ||
| 52-Week Range (€) | 5.1 - 9.8 | ||
| Shares Outstanding (Mil) | 7.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Croma NV Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Croma NV Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Croma NV Frequently Asked Questions
What is Croma NV(STU:QX0)'s stock price today?
The current price of STU:QX0 is €7.50. The 52 week high of STU:QX0 is €9.80 and 52 week low is €5.10.
When is next earnings date of Croma NV(STU:QX0)?
The next earnings date of Croma NV(STU:QX0) is .
Does Croma NV(STU:QX0) pay dividends? If so, how much?
Croma NV(STU:QX0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers